Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Haematologica|May 17, 2020
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomasJakub Svoboda, Steven M Bair, Daniel J Landsburg, et al.Cell Reports|October 7, 2020
TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow MicroenvironmentBac Viet Le, Paulina Podszywalow-Bartnicka, Silvia Maifrede, et al.Cell Reports. Medicine|March 18, 2026
Polθ activity modulates sensitivity to standard therapies in DNMT3A-deficient leukemiaBac Viet Le, Umeshkumar Vekariya, Monika M Toma, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2021
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021Daniel A Pollyea, Dale Bixby, Alexander Perl, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 8, 2023
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in OncologyDaniel A Pollyea, Jessica K Altman, Rita Assi, et al.Blood|December 29, 2022
DNA polymerase θ protects leukemia cells from metabolically induced DNA damageUmeshkumar Vekariya, Monika Toma, Margaret Nieborowska-Skorska, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2026
NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026Daniel A Pollyea, Jessica K Altman, Rita Assi, et al.Leukemia|June 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic NeoplasmsJoseph D Khoury, Eric Solary, Oussama Abla, et al.Pageof 6